Medifast, Inc. (MED) Tops Q4 EPS by 3c; Issues Mixed Outlook

Medifast, Inc. (NYSE: MED) reported Q4 EPS of $0.28, $0.03 better than the analyst estimate of $0.25. Revenue for the quarter came in at $83.2 million versus the consensus estimate of $82.9 million.

Medifast, Inc. sees Q1 2013 EPS of $0.32-0.35, versus the consensus of $0.45. Medifast, Inc. sees Q1 2013 revenue of $93-95 million, versus the consensus of $101.13 million.

Medifast, Inc. sees FY2013 EPS of $1.70-1.80, versus the consensus of $1.76. Medifast, Inc. sees FY2013 revenue of $385-400 million, versus the consensus of $399.6 million.

For earnings history and earnings-related data on Medifast, Inc. (MED) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Adidas (ADDYY) gains after outlook boost
• Vista Outdoor (VSTO) CSG Sends Letter to Senator J.D. Vance Addressing His Concerns Regarding Planned Acquisition of Vista Outdoor’s Sporting Products Business (VSTO)
• Darling Ingredients (DAR) PT Lowered to $62 at JPMorgan